8-127416741-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001159542.3(POU5F1B):​c.875C>G​(p.Ala292Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

POU5F1B
NM_001159542.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0910
Variant links:
Genes affected
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
CASC8 (HGNC:45129): (cancer susceptibility 8)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.062111437).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POU5F1BNM_001159542.3 linkuse as main transcriptc.875C>G p.Ala292Gly missense_variant 1/1 ENST00000696633.1
CASC8NR_117100.1 linkuse as main transcriptn.1176+4088G>C intron_variant, non_coding_transcript_variant
POU5F1BNM_001395745.1 linkuse as main transcriptc.875C>G p.Ala292Gly missense_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POU5F1BENST00000696633.1 linkuse as main transcriptc.875C>G p.Ala292Gly missense_variant 1/1 NM_001159542.3 P1
CASC8ENST00000502082.5 linkuse as main transcriptn.1176+4088G>C intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
111
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 28, 2022The c.875C>G (p.A292G) alteration is located in exon 1 (coding exon 1) of the POU5F1B gene. This alteration results from a C to G substitution at nucleotide position 875, causing the alanine (A) at amino acid position 292 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
2.7
DANN
Benign
0.45
DEOGEN2
Benign
0.00051
T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0098
N
LIST_S2
Benign
0.47
.;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.062
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.69
N;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-0.68
.;N
REVEL
Benign
0.23
Sift
Benign
0.050
.;D
Sift4G
Benign
0.44
.;T
Polyphen
0.031
B;B
Vest4
0.067
MutPred
0.35
Gain of glycosylation at S289 (P = 0.1009);Gain of glycosylation at S289 (P = 0.1009);
MVP
0.099
MPC
0.042
ClinPred
0.054
T
GERP RS
-0.039
Varity_R
0.035
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr8-128428986; API